For example, PGC1α reduces the generation of mitochondrial-driven ROS to promote survival under oxidative stress conditions, and the pro-oxidant drugs PL and PEITC show markedly increased potency in PGC1α-deficient melanoma cells [45]. The gene discussed is PPARGC1A; the disease is melanoma.